BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib.

ABSTRACT:

SUBMITTER: Byrgazov K 

PROVIDER: S-EPMC5777206 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature